Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells
Simona Camorani(Institute for Experimental Endocrinology and Oncology), Laura Cerchia(Institute for Experimental Endocrinology and Oncology)
Cited by 67
Related Papers
Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
|Scientific Reports|2017|93
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
|Theranostics|2017|91
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
|Journal of Experimental & Clinical Cancer Research|2021|82
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2020|70
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
|Journal of Experimental & Clinical Cancer Research|2024|23